Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy

Clinical trial NCT00568035 · COMPLETED

Trial details

NCT number: NCT00568035
Sponsor: Quigley Pharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Neuropathy

Start date: 2006-12-01
Primary completion: 2008-11-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.